{"filings":[{"id":1472443,"accession_number":"0001104659-26-080771","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2026-07-06T20:30:27+00:00","items":["7.01","9.01"],"status":"ready","headline":"Chiron Real Estate acquires SHOP assets for $249M, forms IRF JV for ~$200M, pending Pinnacle acquisition","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Acquired The Riviera and The Landing SHOP communities in June 2026 for $249M total; Riviera 23% occupied, Landing 93% occupied.","Sold seven Inpatient Rehab Facility (IRF) assets into a joint venture, generating ~$200M in proceeds for reinvestment.","Pending acquisition of The Pinnacle for $176M, expected to close 2H 2026; pre-leasing at 36% (64% for IL homes).","Q1 2026 Cash NOI of $28.8M, up from $27.5M in Q1 2025; net income decreased to $1.7M from $3.7M.","Implied portfolio cap rate of 8.7% as of March 31, 2026; adjusted for IRF sale to 8.9%."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1417636,"accession_number":"0001104659-26-080436","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2026-07-02T21:26:58+00:00","items":["1.01","2.01","9.01"],"status":"ready","headline":"Chiron Real Estate sells seven rehab hospitals for $217M, retains 15% JV interest","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Sold seven inpatient rehabilitation hospitals in PA, AZ, TX, NV, OK for $217M; closed June 29, 2026.","Company retains 15% interest in joint venture; U.S. public pension fund holds 85%.","Estimated net cash proceeds of $194.9M after closing costs, transaction costs, and JV investment.","Pro forma shows estimated gain on sale of $70.7M; assets removed from consolidation.","Pro forma net income attributable to common stockholders for FY2025 rises to $43.6M from $(12.1M) historical."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":806838,"accession_number":"0001104659-26-069515","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2026-06-02T20:30:45+00:00","items":["1.01","2.01","2.03","3.02","3.03","5.03","9.01"],"status":"ready","headline":"Chiron Real Estate closes $249M acquisition of two senior housing communities; issues $100M Series C preferred","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired The Landing Alexandria ($130M) and The Riviera Alexandria ($118.9M) on June 1, 2026.","Funded with $100M Series C Preferred Stock private placement and $147M additional Credit Facility borrowings.","Issued 1,000,000 shares of 6.00% Series C Convertible Preferred Stock at $100/share to four institutional investors.","Series C Preferred dividend starts at 6%, steps to 8% after 4 years, then +2% annually to max 12%.","Created 1,000,000 Series C Convertible Preferred Units in the Operating Partnership with substantially similar terms."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":556957,"accession_number":"0001104659-26-064620","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2026-05-20T21:24:13+00:00","items":["5.02","1.01","5.07","7.01","9.01"],"status":"ready","headline":"Chiron appoints Charles Fitzgerald to board; declares Q2 preferred dividends","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Charles Fitzgerald appointed to Board effective May 20, 2026; serves on Compensation and Nominating Committees.","Fitzgerald holds 97,293 shares of common stock via affiliates (~$3.4M), aligning with shareholder interests.","Annual meeting results: all six director nominees elected; 2016 equity plan amendment approved (extend term to 2036, add 300,000 shares).","Q2 2026 preferred dividends: Series A $0.46875/share, Series B $0.50/share, payable July 31, 2026, record July 15."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":93485,"accession_number":"0001104659-26-057976","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2026-05-08T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Chiron Real Estate enters $100M preferred equity deal with Maewyn XRN LP","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Company enters $100M preferred equity purchase agreement with Maewyn XRN LP; initial closing of at least $25M by June 20, 2026.","Series C Preferred Stock carries 6% cumulative dividend, stepping to 8% after 4 years then +2% annually up to 12%.","Initial conversion price set at $43.00 per share of common stock (2.32558 shares per preferred share).","Maewyn receives board nomination and consent rights over debt, REIT status changes, and affiliate deals while holding >=5% of diluted common.","Proceeds to be used for general business and working capital, including potential acquisitions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":93484,"accession_number":"0001104659-26-056346","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2026-05-06T23:59:59+00:00","items":["1.01","2.02","7.01","8.01","9.01"],"status":"ready","headline":"Chiron signs $425M senior housing acquisitions, $100M equity investment, cuts dividend 36%","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Agreed to acquire three senior housing communities in DC metro for ~$425M, expected to close in Q2/Q4 2026.","Secured $100M convertible preferred equity from Maewyn Capital Partners at 6.00%, initial conversion $43/share.","Q1 2026 core FFO $1.11/share (flat YoY), net loss $0.7M; same-property cash NOI up 3.2%.","Reduced monthly dividend from $0.25 to $0.16 (36% cut); new quarterly rate $0.48.","Withdrew 2026 earnings guidance citing portfolio transition; ~$200M asset sales under LOI at ~7% cash yield."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":105147,"accession_number":"0001104659-26-027195","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2026-03-13T23:59:59+00:00","items":["1.01","5.03","8.01","9.01"],"status":"ready","headline":"Chiron Real Estate files for up to $75M Preferred ATM and updates Common ATM with $288M remaining","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Preferred ATM program launched for up to $75M of Series B Preferred Stock; agents get up to 2.0% commission.","Amended Common ATM: up to $288,010,090 in common stock still available; compensation up to 2.0%.","Articles Supplementary filed designating 3M additional Series B Preferred shares, total authorized 5.3M.","Partnership amended to authorize up to an additional 3M Series B Preferred Units (total 5.3M).","Common ATM adds Huntington Securities and Raymond James as sales agents and forward counterparties."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":105146,"accession_number":"0001104659-26-022515","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2026-03-03T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Chiron Real Estate enters $150M uncommitted senior note facility with NYL Investors","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Master Note and Guaranty Agreement with NYL Investors LLC establishes uncommitted facility for up to $150M aggregate principal.","Notes are senior unsecured obligations of Chiron Real Estate LP, maturing up to 10 years; minimum issuance $10M.","Interest rates set at issuance based on spreads over U.S. Treasury securities; no obligation for NYL to purchase notes.","Parent Chiron Real Estate Inc. and subsidiary guarantors provide unconditional guarantees.","Facility available for three years from March 2, 2026; proceeds for general corporate purposes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":105145,"accession_number":"0001104659-26-019760","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2026-02-25T23:59:59+00:00","items":["2.02","5.03","7.01","8.01","9.01"],"status":"ready","headline":"Chiron (XRN) Q4 Core FFO $1.16/sh (+6.4% YoY); FY26 Core FFO guide $4.30-$4.45; switches to monthly dividend","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 GAAP net loss $7.4M ($0.55/sh) vs. prior year net income $1.4M ($0.10/sh).","Q4 Core FFO $1.16/sh, up 6.4% YoY; same-property Cash NOI growth 5.4% YoY.","Full year 2026 Core FFO guidance $4.30-$4.45 per share; no debt maturities in 2026/27.","Dividend switched from quarterly to monthly at $0.25/sh ($3.00 annualized, unchanged); White Rock Medical tenant filed Chapter 11.","Completed $51.3M Series B preferred offering; company renamed from Global Medical REIT to Chiron (XRN)."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.91,"consensus_revenue_estimate":null,"consensus_revenue_actual":148208000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":105148,"accession_number":"0001104659-26-006609","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2026-01-26T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Henry Cole to step down at 2026 Annual Meeting","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Henry Cole notified Board he will leave as director effective at 2026 Annual Meeting.","Cole will not be nominated for re-election; term expires at Annual Meeting.","Departure is not due to any disagreement with the Company on operations or policies.","No replacement director has been announced as of the filing date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121402,"accession_number":"0001104659-25-118474","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2025-12-04T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Ronald Marston to retire at 2026 annual meeting","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Ronald Marston notified board on December 3, 2025 of intent to retire as director.","Retirement effective at the 2026 Annual Meeting of Stockholders; he will not be nominated for reelection.","No replacement announced; board will fill vacancy in due course.","Marston's decision not due to any disagreement with the company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121401,"accession_number":"0001104659-25-113664","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2025-11-18T23:59:59+00:00","items":["1.01","3.03","5.03","9.01"],"status":"ready","headline":"Global Medical REIT to issue 2M shares of 8.00% Series B Preferred Stock at $25/share","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Offering of 2,000,000 shares (plus 300,000 over-allotment) of 8.00% Series B cumulative redeemable preferred stock at $25.00 per share.","Expected to close November 20, 2025; net proceeds will be contributed to the operating partnership for Series B Preferred Units.","Series B Preferred Stock ranks senior to common stock and on parity with existing Series A Preferred Stock; dividend of 8.00% per annum.","Articles Supplementary filed November 18, 2025 with Maryland State Department of Assessments and Taxation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121400,"accession_number":"0001104659-25-110921","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2025-11-13T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Global Medical REIT Q3 2025 net loss of $6.0M vs income $1.8M YoY; occupancy 95.2%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss $6.0M ($0.45/diluted share) vs net income $1.8M ($0.14) in Q3 2024.","Portfolio 95.2% occupied, 5.2M leasable sq ft, annualized base rent $118.4M.","Same-store cash NOI growth 2.7% YoY; Net Debt/Annualized Adjusted EBITDAre 6.9x.","Weighted average lease term 5.3 years; 72% outpatient medical buildings, 25% inpatient facilities.","Q3 2025 net loss included $6.3M impairment on investment property."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.35,"consensus_revenue_estimate":null,"consensus_revenue_actual":109816000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121399,"accession_number":"0001104659-25-106390","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2025-11-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Global Medical REIT Q3 net loss $6.0M vs income $1.8M; FFO/AFFO up 4%; narrows 2025 AFFO guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss $6.0M ($0.45/diluted) vs net income $1.8M ($0.14); includes $6.3M impairment on sold Aurora, IL property.","FFO $14.5M ($1.00/shr+unit) and AFFO $16.2M ($1.12) are each up 4% year-over-year on a per-share basis.","Same-store cash NOI growth 2.7% YoY; leased occupancy 95.2% at Sept 30; rental revenue $37.0M, up 8.4%.","Completed 1-for-5 reverse stock split; established $50M buyback (none executed); amended credit facility extending maturities through 2029-2031.","Narrowed 2025 AFFO guidance to $4.50-$4.60 per share/unit from $4.45-$4.65."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.35,"consensus_revenue_estimate":null,"consensus_revenue_actual":109816000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121398,"accession_number":"0001104659-25-097935","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2025-10-08T23:59:59+00:00","items":["1.01","2.03","7.01","9.01"],"status":"ready","headline":"Global Medical REIT amends credit facility, extends maturities to 2029-2031, enters $350M hedges","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$400M revolver maturity extended to Oct 2029 with two six-month extension options to Oct 2030.","$350M Term Loan A split into three tranches: $100M to Oct 2029, $100M to Oct 2030, $150M to Apr 2031.","Removed 10 bps SOFR credit spread adjustment on all facility borrowings.","Entered $350M forward starting interest rate swaps at fixed base rates 3.24%-3.32%, all-in effective rates 4.75%-4.84%.","Weighted average debt term increased from 1.3 years to 4.4 years at closing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":138054,"accession_number":"0001104659-25-091732","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2025-09-19T23:59:59+00:00","items":["3.03","5.03","7.01","8.01","9.01"],"status":"ready","headline":"Global Medical REIT completes 1:5 reverse stock split; shares to trade on NYSE Sept 22","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Effective Sept 19, 2025, every five shares of common stock converted into one; par value remains $0.001.","Authorized shares reduced from 500M to 100M; outstanding shares cut from 67,037,048 to ~13,407,409.","No fractional shares issued; stockholders receive cash in lieu based on Sept 19 closing price.","Corresponding adjustments made to equity plan shares, outstanding awards, repurchase program, and operating partnership units.","Common stock trades under same symbol GMRE with new CUSIP 37954A303 starting Sept 22."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":138053,"accession_number":"0001104659-25-074239","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2025-08-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Global Medical REIT Q2 net loss narrows to $0.8M; appoints Mark Decker Jr. CEO; reaffirms AFFO guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss narrowed to $0.8M ($0.01/diluted share) from $3.1M loss YoY; FFO $0.20/share, AFFO $0.23/share.","Revenue $37.9M (+10.7% YoY); portfolio 94.5% occupied, 5.2M sq ft, annualized base rent $117.5M.","Acquired $69.6M five-property medical portfolio at 9.0% cap rate with $6.3M annualized base rent.","Appointed Mark Decker Jr. as CEO, President, and Board member effective June 2025.","Reaffirmed FY2025 AFFO guidance of $0.89-$0.93 per share; declared $0.15/share common dividend."],"consensus_eps_estimate":null,"consensus_eps_actual":0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":72587000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":155464,"accession_number":"0001104659-25-061389","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2025-06-23T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"GMRE appoints Mark Decker as CEO; Jeffrey Busch becomes non-executive Chairman","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Mark O. Decker, Jr. appointed CEO and President effective June 23, 2025; also joins Board.","Jeffrey M. Busch removed as CEO and President; continues as non-executive Chairman.","Decker's base salary $700k; target annual bonus at 100% of base; initial LTIP award $1M.","Decker previously CEO of Centerspace (NYSE:CSR) and co-led net lease strategy at Proterra.","Relocation assistance of $75k provided; severance includes 2x salary+bonus on qualifying termination."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":155463,"accession_number":"0001104659-25-053594","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2025-05-28T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Global Medical REIT cuts quarterly common dividend from $0.21 to $0.15 per share","summary_kind":"llm","event_type":"dividend","confidence":"high","bullets":["Board declared Q2 2025 common dividend of $0.15/share, down from $0.21; payable July 9 to holders of record June 20.","Dividend reduction expected to retain over $17M annually, strengthening balance sheet and funding future growth.","YTD 2025: $69.6M in acquisitions (5 properties) at 9.0% cap rate; $8.2M dispositions with $1.4M gain.","Beaumont, TX facility re-leased to CHRISTUS Health for 15 years at $2.9M annual rent, replacing bankrupt Steward Health.","Series A Preferred dividend maintained at $0.46875/share, payable July 31."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":155462,"accession_number":"0001104659-25-048999","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2025-05-15T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Global Medical REIT stockholders elect seven directors, ratify auditor, approve say-on-pay","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All seven director nominees elected with at least 38M votes for; no dissident candidates.","Advisory vote on executive compensation passed with 37.8M for vs 1.4M against.","Ratification of Deloitte & Touche LLP as auditor received 52.5M for, 212k against.","Broker non-votes of ~12.9M on director and compensation proposals; none on auditor ratification."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":155461,"accession_number":"0001104659-25-045612","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2025-05-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GMRE Q1 net income $2.1M ($0.03/diluted); AFFO $0.22/unit; reaffirms FY2025 AFFO guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $2.1M ($0.03/diluted) vs $0.8M ($0.01) prior year; AFFO $0.22/unit vs $0.23.","Rental revenue $34.6M, down 1.4% YoY; portfolio occupancy 95.6% at March 31, 2025.","Completed $69.6M five-property medical portfolio at 9.0% cap rate; financed via credit facility.","Prospect Medical filed Ch.11; owed $2.4M; East Orange lease rejected; $250k post-petition paid.","FY2025 AFFO guidance reaffirmed $0.89-$0.93 per share/unit; dividend held at $0.21/quarter."],"consensus_eps_estimate":0.0101,"consensus_eps_actual":0.16,"consensus_revenue_estimate":null,"consensus_revenue_actual":34618000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl+finnhub","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173957,"accession_number":"0001104659-25-018306","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2025-02-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GMRE Q4 AFFO $0.22/unit flat YoY; JV with Heitman; 2025 guidance $0.89-$0.93","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2024 net income $1.4M ($0.02/diluted) vs net loss $0.8M (-$0.01) in Q4 2023; full-year net income $0.8M ($0.01) vs $14.8M ($0.23).","Q4 AFFO $15.8M ($0.22/unit) vs $15.9M ($0.23) prior year; full-year AFFO $63.4M ($0.89) vs $64.3M ($0.91).","Acquired $80.3M of net-lease medical assets in 2024 at 8.0% cap rate; entered JV with Heitman (12.5% stake) and contributed two assets for $35.2M.","CEO Jeff Busch to step down by June 30, 2025; $3.2M severance charge recorded in Q4; search for successor underway.","Full-year 2025 AFFO guidance introduced at $0.89-$0.93 per share/unit; Q1 2025 common dividend maintained at $0.21/share."],"consensus_eps_estimate":null,"consensus_eps_actual":0.01,"consensus_revenue_estimate":null,"consensus_revenue_actual":138780000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173956,"accession_number":"0001104659-25-002062","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2025-01-08T23:59:59+00:00","items":["5.02","7.01","8.01","9.01"],"status":"ready","headline":"CEO Jeff Busch to step down by June 30, 2025; will remain as non-executive chairman","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Jeffrey Busch to leave by earlier of successor appointment or June 30, 2025; to continue as non-executive chairman.","Board started CEO search with executive search firm; Busch will stand for re-election as director at 2025 annual meeting.","Lori Wittman appointed Lead Independent Director effective January 1, 2025.","Separation agreement provides transition benefits; departure not due to any disagreement with company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":190930,"accession_number":"0001104659-24-119735","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2024-11-15T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Global Medical REIT updates investor presentation; YTD acquisitions $80.3M at 8.0% cap rate","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["YTD 2024: $80.3M in acquisitions (15 properties, 254k SF) at 8.0% WA cap rate.","Assets under contract: $69.6M at 9.0% cap rate, expected close first half 2025.","Beaumont, TX facility: new 15-year lease with CHRISTUS Health at $2.9M base rent, 2.5% annual escalations.","Q3 2024 ATM issuance: 1.2M shares at avg $9.95, gross proceeds $12M.","Portfolio: 96.1% occupancy, 7.7% WA cap rate, 9.4% dividend yield based on $8.89 stock price."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":190929,"accession_number":"0001104659-24-114813","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2024-11-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GMRE Q3 net income $1.8M ($0.03/diluted), FFO $0.19/unit, AFFO $0.22/unit","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Rental revenue $34.2M, down 3.7% YoY; net income fell from $3.1M to $1.8M.","Completed $30.8M acquisitions in Q3; total $80.3M 15-property portfolio closed.","Entered agreement to buy $69.6M, 5-property portfolio at 9.0% cap rate, close H1 2025.","Steward lease rejection allowed new 15-year lease with CHRISTUS Health; rent starts March/April 2025.","Issued 1.2M shares via ATM at $9.95 for $12M; portfolio occupancy 96.1%, leverage 44.1%."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.04,"consensus_revenue_estimate":null,"consensus_revenue_actual":103624000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207415,"accession_number":"0001104659-24-100451","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2024-09-17T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"GMRE signs 15-year triple-net lease with CHRISTUS Health at Beaumont facility after Steward bankruptcy rejection","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["New 15-year triple-net lease with CHRISTUS Health at Beaumont, TX facility for robotic surgery, orthopedics, emergency services.","Steward Health Care requested lease rejection as of Sept 15, 2024, as part of its Chapter 11 bankruptcy; final order pending with court.","CEO Jeffrey M. Busch says quick re-leasing demonstrates importance of underwriting tenant and building; delivers excellent outcome.","CHRISTUS Health is a high-quality tenant; facility previously leased to Steward which filed for Chapter 11 on May 6, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207414,"accession_number":"0001104659-24-086337","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2024-08-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Global Medical REIT Q2 net loss $3.1M; Steward risk; $30.8M acquisition closed","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss attributable to common stock of $3.1M ($0.05/diluted) vs income $11.8M ($0.18) Q2 2023; includes $3.4M loss on sale.","FFO $13.9M ($0.20/share) and AFFO $15.7M ($0.22/share) vs $14.7M ($0.21) and $15.9M ($0.23) YoY.","Entered agreement to acquire 15-property portfolio for $80.3M; closed first tranche (5 properties) for $30.8M in July; second tranche expected Q4 2024.","Tenant Steward Health Care (2.8% of ABR) filed Chapter 11; rent received for June–August, but no assurance of full recovery.","Portfolio occupancy 96.2%; leverage 43.8%; dividend unchanged at $0.21/share."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.04,"consensus_revenue_estimate":null,"consensus_revenue_actual":69360000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":224827,"accession_number":"0001104659-24-069129","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K/A","filed_at":"2024-06-06T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Global Medical REIT board sets annual say-on-pay vote after stockholder advisory result","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Advisory vote: 34,040,745 for every year, 158,991 for two years, 1,098,203 for three years, 566,323 abstained, 13,706,822 broker non-votes.","Board of Directors determined future say-on-pay votes will be held every year.","Decision aligns with board's prior recommendation in April 1, 2024 proxy statement.","Amendment filed solely to disclose the frequency determination; no other changes to original 8-K."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":224831,"accession_number":"0001104659-24-067845","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2024-06-03T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Global Medical REIT posts updated investor presentation; no material new information","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Presentation dated June 3, 2024, posted on company website; no earnings or guidance changes.","Key portfolio stats as of March 31, 2024: 96.4% occupancy, 4.8x rent coverage, 5.8-yr avg lease term.","Weighted average acquisition cap rate 7.9%; dividend yield 9.0% based on $9.29 closing price.","Debt profile: 84% fixed-rate, 2.7-yr weighted avg maturity, $280M undrawn revolver available.","No material events disclosed; routine presentation update for investor relations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":224830,"accession_number":"0001104659-24-062602","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2024-05-16T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Global Medical REIT shareholders approve 1.5M share increase to equity incentive plan at 2024 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Stockholders approved amendment to 2016 Equity Incentive Plan, increasing reserved shares by 1,500,000.","All seven director nominees were elected, including Jeffrey M. Busch, Matthew Cypher, and Ronald Marston.","Ratification of Deloitte & Touche as independent auditor for fiscal 2024 received 48.8M votes for, 608K against.","Advisory vote on named executive officer compensation passed with 33.8M for, 1.5M against; frequency advisory set at every 1 year."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":224829,"accession_number":"0001104659-24-058072","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2024-05-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GMRE Q1 net income $0.8M, AFFO $0.23/share; Steward Health Care files Chapter 11","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $0.8M ($0.01/diluted share); FFO $14.9M ($0.21/unit); AFFO $16.5M ($0.23/unit).","Rental revenue $35.1M, down 3% YoY due to 2023 property dispositions.","Steward Health Care (2.8% of ABR) filed Chapter 11; $0.5M receivable at risk.","Entered agreement to buy 15-property portfolio for $81.3M, closing in H2 2024.","Leverage flat at 44.0%; quarterly common dividend maintained at $0.21/share."],"consensus_eps_estimate":null,"consensus_eps_actual":0.01,"consensus_revenue_estimate":null,"consensus_revenue_actual":35118000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":224828,"accession_number":"0001104659-24-044305","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2024-04-05T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Global Medical REIT transfers ATM program to new registration after losing WKSI status","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Filed Prospectus Supplement to move ATM Program from Post-Effective Amendment No.1 to No.2.","Company no longer qualifies as a well-known seasoned issuer per Rule 405 after 2023 10-K filing.","No change in offering terms; purely administrative registration update.","Legal opinion from Venable LLP included as Exhibit 5.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":244101,"accession_number":"0001104659-24-031048","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2024-03-05T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Global Medical REIT moves ATM program to post-effective amendment after losing WKSI status","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Company no longer qualifies as well-known seasoned issuer after filing 2023 Form 10-K.","ATM program moved from WKSI Shelf (S-3ASR) to Post-Effective Amendment No. 1.","Prospectus supplement filed Feb 27, 2024; Venable LLP opinion included as Exhibit 5.1.","No change to offering terms; purely administrative shelf transfer."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":244100,"accession_number":"0001104659-24-028236","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2024-02-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Global Medical REIT posts Q4 net loss of $0.8M; full-year AFFO $0.91/share, leverage down to 43.6%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net loss attributable to common stockholders of $0.8M ($0.01 diluted loss per share), vs net income $0.4M in Q4 2022.","Q4 FFO $13.3M ($0.19/share), down from $15.5M ($0.22/share) YoY; AFFO $15.9M ($0.23/share) vs $16.5M ($0.24/share) YoY.","Total revenue $33.0M, down 9.2% YoY, due to dispositions and $1.1M rent reserve recognized.","Full-year 2023 dispositions generated $80.5M gross proceeds; leverage reduced to 43.6% from 47.6% at year-end 2022.","Portfolio 96.5% occupied; acquisition pipeline $95M-$110M for 2024; no ATM issuance in 2023 or YTD 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":0.23,"consensus_revenue_estimate":null,"consensus_revenue_actual":141049000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":244099,"accession_number":"0001104659-24-002641","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2024-01-09T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Global Medical REIT registers $300M at-the-market equity program with forward sale option","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Agreement with 14 agents and 9 forward sellers to sell up to $300M in common stock via ATM offerings.","Agents and forward sellers will receive up to 2.0% of gross proceeds as compensation.","Forward sale mechanism allows borrowing and selling shares; company expects physical settlement for cash.","Program filed under existing S-3 shelf; prospectus supplement dated Jan 9, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":261513,"accession_number":"0001104659-23-117319","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2023-11-13T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Global Medical REIT updates investor presentation; portfolio 96.7% occupied, $1.4B gross assets","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Portfolio: 185 buildings, 268 tenants, 4.7M sq ft, 96.7% occupancy as of Sept 30, 2023.","$1.4B gross real estate assets, $0.6B market cap; 7.9% weighted avg cap rate, 9.1% dividend yield.","Debt: $626M total, 89% fixed rate, weighted avg interest 3.78%, maturity 3.1 years.","Dividend held at $0.85/share annualized; no reduction during COVID; strong tenant base cited.","Strategy focuses on off-campus medical offices and post-acute facilities with 5.7 yr avg lease term."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":261512,"accession_number":"0001104659-23-114779","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2023-11-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GMRE Q3 net income $3.1M ($0.05/diluted), FFO $0.22, revenue $35.5M; occupancy 96.7%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income attributable to common stockholders $3.1M ($0.05/diluted) vs $8.1M ($0.12) in prior-year Q3.","FFO $15.3M ($0.22/unit) vs $16.2M ($0.23); AFFO $16.5M ($0.23) vs $17.1M ($0.25).","Year-to-date completed three dispositions for $80.5M gross proceeds with $15.6M total gain.","Portfolio leased occupancy 96.7%; weighted average lease term 5.7 years; rent coverage 4.2x.","Dividend of $0.21/common share declared; leverage 44.2%; weighted avg interest rate 3.78%."],"consensus_eps_estimate":null,"consensus_eps_actual":0.24,"consensus_revenue_estimate":null,"consensus_revenue_actual":108088000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":278730,"accession_number":"0001104659-23-086866","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2023-08-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Global Medical REIT Q2 net income $11.8M; core FFO/AFFO down YoY; reduces leverage to 44.5%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $11.8M ($0.18/diluted) vs $2.2M ($0.03) in prior year; includes $12.8M gain on sale.","FFO $14.7M ($0.21/share) vs $16.4M ($0.24); AFFO $15.9M ($0.23) vs $17.6M ($0.25); both down YoY.","Revenue $36.4M, +7.9% YoY; portfolio leased occupancy 97%.","Sold four MOB portfolio in Oklahoma City for $66M gross; used proceeds to cut variable-rate debt; leverage 44.5%.","Acquired two MOBs in Redding, CA for $6.7M at 7.6% cap rate."],"consensus_eps_estimate":null,"consensus_eps_actual":0.19,"consensus_revenue_estimate":null,"consensus_revenue_actual":72581000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":296967,"accession_number":"0001104659-23-068310","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2023-06-06T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Global Medical REIT updates investor presentation with portfolio data as of March 31, 2023","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Portfolio occupancy 97%, weighted average lease term 6.0 years, 188 buildings, 274 tenants.","Dividend yield 9.4% based on $8.89 stock price; annual dividend $0.85 per share in 2022.","Total gross debt $701M, 80% fixed rate, weighted average interest rate 4.28%, maturity 3.7 years.","Unutilized revolver capacity $252M and common equity ATM capacity $298M.","Acquisition cap rate target 7.5%-8.0%; weighted average cap rate 7.8% on $1.5B gross real estate."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":296966,"accession_number":"0001104659-23-060895","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2023-05-15T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Global Medical REIT posts updated investor presentation; portfolio metrics as of March 31, 2023","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Portfolio occupancy 97%, weighted-average lease term 6.0 years, 188 buildings, 274 tenants.","Acquired $1.5B gross real estate since IPO; $149M in 2022 and $7M year-to-date 2023.","Debt profile: 80% fixed-rate, weighted-average interest rate 4.28%, $256.5M revolver available.","No new financial guidance or material operational changes disclosed in presentation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":296965,"accession_number":"0001104659-23-058486","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2023-05-10T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Global Medical REIT annual meeting results: all directors elected, say-on-pay passed, auditor ratified","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All seven nominated directors elected with 33.5M to 35.1M votes in favor; broker non-votes of ~14.5M.","Advisory vote on named executive officer compensation approved: 33.6M for, 1.3M against, 693K abstain.","Ratification of Deloitte & Touche LLP as independent auditor for 2023: 49.8M for, 102K against, 112K abstain.","Annual meeting held on May 10, 2023; all proposals passed with no material opposition."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":296964,"accession_number":"0001104659-23-055537","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2023-05-03T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Global Medical REIT Q1 net income $0.7M ($0.01/shr); FFO $15.1M ($0.22/shr); revenue $36.2M (+13.7% YoY)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $0.7M ($0.01 diluted EPS) vs $2.7M ($0.04) YoY; FFO $15.1M ($0.22/shr) vs $16.0M ($0.23); AFFO $16.0M ($0.23) vs $16.8M ($0.24).","Rental revenue $36.2M (+13.7% YoY) driven by acquisitions; portfolio leased occupancy 97.0% (up from 96.5% Dec 2022).","Sold Jacksonville MOB for $4.4M (gain $0.5M); completed $6.7M Redding, CA acquisition on April 17 funded by OP Units at $11.00/unit.","Dividend $0.21/shr common payable April 11; leverage 47.4%; weighted avg interest rate 4.28%; $244.5M undrawn credit facility.","No shares issued under ATM in Q1 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":0.01,"consensus_revenue_estimate":null,"consensus_revenue_actual":36230000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":317347,"accession_number":"0001104659-23-026821","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2023-02-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Global Medical REIT Q4 net income falls to $0.01 EPS; revenue up 19.6% to $36.3M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net income $0.4M ($0.01 diluted EPS) vs $3.8M ($0.06) YoY; AFFO flat at $0.24/share.","Full-year FFO $64.0M ($0.92/share) vs $58.2M ($0.90); AFFO $68.0M ($0.98) vs $61.4M ($0.95).","Completed 14 acquisitions totaling $148.9M at 7.4% cap rate; sold one property for $17.9M (gain $6.8M).","Leverage increased to 47.6% (from 43.0% year-end 2021); weighted avg interest rate 4.20%, up from 2.88% in Q4'21.","Q4 dividend $0.21/share common, unchanged; no ATM issuances in Q4."],"consensus_eps_estimate":null,"consensus_eps_actual":0.2,"consensus_revenue_estimate":null,"consensus_revenue_actual":137283000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":317346,"accession_number":"0001104659-23-005808","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2023-01-23T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Dr. Roscoe Moore to retire at 2023 Annual Meeting, not seeking re-election","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dr. Roscoe Moore, Jr. notified Board of intent to retire as director, effective at 2023 Annual Meeting.","He will not be nominated for re-election; his term ends on the date of the Annual Meeting.","Decision was not due to any disagreement with Company's operations, policies, or practices."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":335589,"accession_number":"0001104659-22-125184","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2022-12-07T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Global Medical REIT adopts amended bylaws to comply with federal proxy rules","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Board adopted Fourth Amended and Restated Bylaws effective December 7, 2022, to ensure compliance with Rule 14a-19 under the Exchange Act.","Stockholders soliciting proxies must use a proxy card color other than white; white proxy card reserved for Board use.","Director nomination notices must now include a written undertaking to solicit holders of at least 67% voting power.","Company may disregard proxy authority for any nominee if the soliciting stockholder abandons or fails to comply with Rule 14a-19."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":335588,"accession_number":"0001104659-22-118621","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2022-11-14T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Global Medical REIT updates investor presentation with 97% occupancy, $149M YTD acquisitions","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Portfolio as of Sept 30, 2022: 97% occupied, 6.4-year WALT, 189 buildings, 4.9M sq ft.","Acquired $149M year-to-date 2022; $1.5B total since IPO; weighted avg cap rate 7.7%.","Debt profile: $703M total gross debt, 79% fixed-rate, 3.9% avg interest, 4.2-year avg maturity; $250M revolver available.","Dividend yield 8.7% based on $9.59 close; Pipeline Healthcare (tenant) filed Chapter 11 in Oct 2022.","Rent coverage 4.7x; weighted avg rent escalations 2.1%."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":335587,"accession_number":"0001104659-22-114000","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2022-11-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Global Medical REIT Q3 net income $8.1M, AFFO $0.25/share; adds $150M term loan, 80% fixed-rate debt","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $8.1M ($0.12 diluted EPS) vs $3.7M ($0.06) prior year; revenue $35.4M, up 18.1% YoY","FFO $16.2M ($0.23/sh/unit) flat; AFFO $17.1M ($0.25) up from $0.24 prior year","Acquired $50.8M in Q3 (247k sf at 7.1% cap); YTD $148.9M; sold one asset for $17.9M, $6.8M gain","Amended credit facility: $150M term loan added (Feb 2028), revolver extended to Aug 2026, switched to SOFR","Entered $150M interest rate swaps fixing SOFR at 2.54%; 80% of debt now fixed at 3.75% wtd avg rate"],"consensus_eps_estimate":null,"consensus_eps_actual":0.2,"consensus_revenue_estimate":null,"consensus_revenue_actual":100977000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":335586,"accession_number":"0001104659-22-106531","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2022-10-06T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"GMRE tenant Pipeline Health files Chapter 11; rent current, White Rock not primary cause","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Pipeline Health System, sole tenant at GMRE's White Rock Medical Center, filed Chapter 11 on Oct 3.","Pipeline cites labor/reimbursement pressures; primary cause is Chicago facilities, not White Rock.","Pipeline intends to keep hospitals open during restructuring; rent payments to GMRE currently current.","GMRE is monitoring the reorganization and will provide market updates as appropriate."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":353027,"accession_number":"0001104659-22-085665","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2022-08-03T23:59:59+00:00","items":["1.01","2.02","2.03","9.01"],"status":"ready","headline":"GMRE Q2 AFFO $0.25/shr (+8.7% YoY); revenue $33.7M; adds $150M term loan","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $2.2M ($0.03/shr) vs $2.6M prior year; FFO $0.24/shr, AFFO $0.25/shr.","Revenue $33.7M, up 19.2% YoY on acquisition growth; portfolio 96.5% occupied.","Q2 acquisitions $74.1M at 6.9% cap rate; YTD $121.3M at 7.1% cap rate.","Credit facility: $150M delayed-draw term loan, revolver extended to Aug 2026, SOFR-based.","Leverage 46.2%; pro-forma borrowing capacity $273M; entered $150M interest rate swaps."],"consensus_eps_estimate":null,"consensus_eps_actual":0.07,"consensus_revenue_estimate":null,"consensus_revenue_actual":65572000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":370666,"accession_number":"0001104659-22-075008","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2022-06-28T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Global Medical REIT updates investor presentation; termination of $44.6M Belpre property sale disclosed","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["As of June 24, 2022, purchaser terminated contract to sell Belpre, OH property for $44.6M; asset remains in portfolio.","Portfolio: 97% occupied, 171 buildings, 201 tenants, 4.4M sq ft; weighted avg lease term 6.9 yrs, rent coverage 5.0x.","$98M acquisitions YTD 2022, $31M under contract; $1.4B total real estate investments since IPO.","Leverage ratio 43.7% as of March 31, 2022; $135M available capacity as of June 24, 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":454480000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2022-06-28T23:59:59+00:00|370666"}